XELTIN TOFACITINIB 5MG TABLETS 30’S

Xeltin (tofacitinib) is an oral Janus kinase (JAK) inhibitor used primarily for the treatment of autoimmune conditions. It is commonly prescribed for moderate to severe rheumatoid arthritis in adults who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs). Tofacitinib works by inhibiting the JAK pathways, which play a crucial role in the inflammatory process, thereby reducing inflammation and preventing joint damage.

In addition to rheumatoid arthritis, Xeltin is also used for treating psoriatic arthritis and ulcerative colitis. The typical dosage is 5 mg taken twice daily, and it is available in a pack of 30 tablets. Patients using Xeltin should be monitored for potential side effects, including infections, changes in blood counts, and liver enzyme elevations. Overall, Xeltin provides an effective treatment option for managing chronic inflammatory conditions.